PeptiDream Inc., a public Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter "PeptiDream")(Tokyo: 4587), announced the achievement of a preclinical development milestone in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback